# Stryker CDR (CAD Hedged) (SYK.TO) fundamentals

Data as of 2026-11-04. TSX, Canada. Sector: Healthcare / Medical Devices & Supplies. Price C$20.91, market value C$8.0 billion.

## Valuation
- **P/E (trailing): 33.2×**. Stryker CDR (CAD Hedged) trades at 33.2× trailing earnings. The Healthcare median in the September 2026 study was 28.5×.
- **Price / sales: 0.3×**. Each dollar of revenue is priced at 0.3×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.0×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 2.8×**. Enterprise value is 2.8× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 59.1%**. Free cash flow equals 59.1% of the market value. Above 5% is generally attractive.
- **Earnings yield: 3.0%**. The inverse of the P/E: 3.0% of the price is earned each year.

## Profitability
- **Gross margin: 65.0%**. Stryker CDR (CAD Hedged) keeps 65.0% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 21.7%**. 21.7% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 12.9%**. 12.9% of each dollar of sales reaches the bottom line.
- **Return on equity: 14.5%**. 14.5% on shareholders' equity is solid.
- **Return on invested capital: 11.9%**. Return on all capital, debt included, is 11.9%.
- **Return on assets: 7.8%**. Each dollar of assets produces 7.8% of profit.

## Growth
- **Revenue growth (1 yr): 11.2%** (3-yr 10.8%/yr). Revenue grew 11.2% over the last year.
- **EPS growth (1 yr): 8.2%** (3-yr 10.8%/yr). Earnings per share rose 8.2%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 28.1%/yr**. Free cash flow has compounded at 28.1% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.71**. Debt is 0.71 times equity, moderate leverage.
- **Net debt / EBITDA: 1.7×**. It would take 1.7 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 1.89** (quick 1.21). Current assets cover the next year's liabilities 1.89 times.
- **Altman Z-score: 1.88**. A Z-score of 1.88 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Stryker CDR (CAD Hedged) does not currently pay a dividend.

## Price and momentum
- **From 52-week high: -13.9%** (15.7% above the low). Trading 14% below its 52-week high.
- **RSI (14-day): 48**. An RSI of 48 is neutral.
- **Beta (1 yr): 0.58** (volatility 36%). Beta of 0.58 against the S&P/TSX Composite: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SYK.TO · Page: https://foliofundamentals.com/stocks/syk.to

Not investment advice.